Edition:
United Kingdom

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

0.35USD
24 Apr 2018
Change (% chg)

$-0.00 (-0.03%)
Prev Close
$0.35
Open
$0.35
Day's High
$0.35
Day's Low
$0.34
Volume
6,306
Avg. Vol
29,197
52-wk High
$1.42
52-wk Low
$0.30

Latest Key Developments (Source: Significant Developments)

Biolase Has Asked Jonathan Lord Chairman Of Board Of Biolase, To Lead Co's Exploration Of Strategic Alternatives
Wednesday, 11 Apr 2018 

April 11 (Reuters) - BIOLASE Inc ::HAS ASKED JONATHAN T. LORD CHAIRMAN OF BOARD OF BIOLASE, TO LEAD CO'S EXPLORATION OF STRATEGIC ALTERNATIVES.BOARD HAS ALSO APPOINTED CHIEF FINANCIAL OFFICER JOHN BEAVER AS INTERIM CHIEF EXECUTIVE OFFICER.BEAVER REPLACES HAROLD FLYNN, JR., WHO HAS RESIGNED FROM HIS POSITIONS AS PRESIDENT AND CHIEF EXECUTIVE OFFICER.STRATEGIC ALTERNATIVES MAY INCLUDE A MERGER OR OTHER BUSINESS COMBINATION WITH ANOTHER PARTY.  Full Article

Biolase Files For Possible Resale Of Up To 21.9 Mln Shares Of Common Stock By Selling Stockholders
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Biolase Inc ::BIOLASE INC FILES FOR POSSIBLE RESALE OF UP TO 21.9 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Biolase reports Q3 non-GAAP loss per share $0.05
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Biolase Inc :Biolase reports 2017 third quarter and nine-month results.Q3 non-GAAP loss per share $0.05.Q3 loss per share $0.06.Q3 revenue rose 18 percent to $10.8 million.  Full Article

Biolase appoints Richard Lanman to board of directors
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Biolase Inc ::Biolase appoints Richard B. Lanman to board of directors.Biolase - ‍Lanman replaces outgoing director Fredrick Moll​.  Full Article

Biolase Q2 loss per share $0.06
Monday, 1 Aug 2016 

Biolase Inc : Biolase Reports 2016 Second Quarter And Six-Month results . Q2 revenue rose 16 percent to $13.8 million .Q2 loss per share $0.06.  Full Article

Biolase to raise $10 mln in convertible preferred private placement
Monday, 1 Aug 2016 

Biolase Inc : Biolase to raise $10 million from institutional and individual investors in convertible preferred private placement .Has agreed to sell an aggregate of 88,494 shares of its convertible preferred stock at a per share price of $113.00.  Full Article

Biolase reports Q1 loss per share $0.07
Monday, 9 May 2016 

Biolase Inc : Biolase reports 2016 first quarter results . Q1 loss per share $0.07 .Q1 revenue rose 1.4 percent to $11 million.  Full Article

BRIEF-Biolase Has Asked Jonathan Lord Chairman Of Board Of Biolase, To Lead Co's Exploration Of Strategic Alternatives

* HAS ASKED JONATHAN T. LORD CHAIRMAN OF BOARD OF BIOLASE, TO LEAD CO'S EXPLORATION OF STRATEGIC ALTERNATIVES